CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...